Skip to main content
SpringerLink
Log in

Cladribine

Lymphopenia: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • De Angelis M, et al. Mild or no COVID-19 symptoms in cladribine-treated multiple sclerosis: Two cases and implications for clinical practice. Multiple Sclerosis and Related Disorders 45: 102452, Oct 2020. Available from: URL: http://doi.org/10.1016/j.msard.2020.102452

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cladribine. Reactions Weekly 1821, 79 (2020). https://doi.org/10.1007/s40278-020-83199-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-83199-1

Search

Navigation